Sobi (Swedish Orphan Biovitrum AB)
(https://synagis.com) 📸 Data Snapshot: June 19, 2026Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Authority is well-established through robust schema data, including Organization and MedicalOrganization types with links to Wikipedia and professional social footprints. There are no ‘unverifiable expert’ red flags; the company presents as a corporate entity rather than a personality-led brand, and its head office address in Stockholm is clearly provided.
Marketing claims such as ‘unlocking potential’ are tempered by the inclusion of a Results Centre and specific financial reporting dates (July 16, 2026). The site demonstrates its activity through recent news about ‘pegcetacoplan’ data, bridging the gap between high-level promises and actual clinical participation.
Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
Homepage schema
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "Organization",
"additionalType": "MedicalOrganization",
"@id": "https://www.sobi.com/",
"description": "Sobi is an international biopharmaceutical company focused on rare diseases.",
"name": "Sobi",
"sameAs": [
"https://en.wikipedia.org/wiki/Swedish_Orphan_Biovitrum",
"https://www.linkedin.com/company/sobi/",
"https://www.youtube.com/c/Sobi-Pharma"
],
"url": "https://www.sobi.com/",
"telephone": "+4686972000",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+4686972000",
"email": "info@sobi.com",
"url": "https://www.sobi.com/",
"availableLanguage": [
"English",
"Swedish"
]
},
"image": {
"@type": "ImageObject",
"url": "https://www.sobi.com/sites/sobi/files/styles/banner/public/images/young-kid-leaves.jpg.webp?itok=DwHwUQ3X"
},
"logo": {
"@type": "ImageObject",
"representativeOfPage": "True",
"url": "https://www.sobi.com/themes/sobi/img/logo.svg",
"width": "284",
"height": "108"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "Box",
"addressLocality": "Stockholm",
"postalCode": "SE-112 76",
"addressCountry": "Sweden"
}
}
]
}
/middle-east/en/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "Organization",
"additionalType": "MedicalOrganization",
"@id": "https://www.sobi.com/",
"description": "Sobi is an international biopharmaceutical company focused on rare diseases.",
"name": "Sobi",
"sameAs": [
"https://en.wikipedia.org/wiki/Swedish_Orphan_Biovitrum",
"https://www.linkedin.com/company/sobi/",
"https://www.youtube.com/c/Sobi-Pharma"
],
"url": "https://www.sobi.com/",
"telephone": "+4686972000",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+4686972000",
"email": "info@sobi.com",
"url": "https://www.sobi.com/",
"availableLanguage": [
"English",
"Swedish"
]
},
"image": {
"@type": "ImageObject",
"url": "https://www.sobi.com/sites/sobi/files/styles/banner/public/images/young-kid-leaves.jpg.webp?itok=DwHwUQ3X"
},
"logo": {
"@type": "ImageObject",
"representativeOfPage": "True",
"url": "https://www.sobi.com/themes/sobi/img/logo.svg",
"width": "284",
"height": "108"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "Box",
"addressLocality": "Stockholm",
"postalCode": "SE-112 76",
"addressCountry": "Sweden"
}
}
]
}
/en/pipeline/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "Organization",
"additionalType": "MedicalOrganization",
"@id": "https://www.sobi.com/",
"description": "Sobi is an international biopharmaceutical company focused on rare diseases.",
"name": "Sobi",
"sameAs": [
"https://en.wikipedia.org/wiki/Swedish_Orphan_Biovitrum",
"https://www.linkedin.com/company/sobi/",
"https://www.youtube.com/c/Sobi-Pharma"
],
"url": "https://www.sobi.com/",
"telephone": "+4686972000",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+4686972000",
"email": "info@sobi.com",
"url": "https://www.sobi.com/",
"availableLanguage": [
"English",
"Swedish"
]
},
"image": {
"@type": "ImageObject",
"url": "https://www.sobi.com/sites/sobi/files/styles/banner/public/images/young-kid-leaves.jpg.webp?itok=DwHwUQ3X"
},
"logo": {
"@type": "ImageObject",
"representativeOfPage": "True",
"url": "https://www.sobi.com/themes/sobi/img/logo.svg",
"width": "284",
"height": "108"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "Box",
"addressLocality": "Stockholm",
"postalCode": "SE-112 76",
"addressCountry": "Sweden"
}
}
]
}
/en/careers/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "Organization",
"additionalType": "MedicalOrganization",
"@id": "https://www.sobi.com/",
"description": "Sobi is an international biopharmaceutical company focused on rare diseases.",
"name": "Sobi",
"sameAs": [
"https://en.wikipedia.org/wiki/Swedish_Orphan_Biovitrum",
"https://www.linkedin.com/company/sobi/",
"https://www.youtube.com/c/Sobi-Pharma"
],
"url": "https://www.sobi.com/",
"telephone": "+4686972000",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+4686972000",
"email": "info@sobi.com",
"url": "https://www.sobi.com/",
"availableLanguage": [
"English",
"Swedish"
]
},
"image": {
"@type": "ImageObject",
"url": "https://www.sobi.com/sites/sobi/files/styles/banner/public/images/young-kid-leaves.jpg.webp?itok=DwHwUQ3X"
},
"logo": {
"@type": "ImageObject",
"representativeOfPage": "True",
"url": "https://www.sobi.com/themes/sobi/img/logo.svg",
"width": "284",
"height": "108"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "Box",
"addressLocality": "Stockholm",
"postalCode": "SE-112 76",
"addressCountry": "Sweden"
}
}
]
}
🛡️ Trust Signals — external proof links that back the declared identity
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
| /middle-east/en/ | 0 | 0 |
| /en/pipeline/ | 0 | 0 |
| /en/careers/ | 0 | 0 |
This page presents a snapshot of public data from Sobi (Swedish Orphan Biovitrum AB), captured on June 19, 2026, to show how machine logic reads Identity & Authority signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Sobi (Swedish Orphan Biovitrum AB): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://synagis.com to view the most current version of its content and see directly what this company is about and what it offers.